Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 31

Trial Status

Completed2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT00003641Phase 3Completed
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Melanoma (Skin)
StudychairStart date: 1999-03-25
NCT00003451Phase 1Completed
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Studychair

Research Network

Collaboration Network

11 collaborators·24 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesChronic Myeloproliferative Disorders+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

Sanjiv S. Agarwala, MD

St. Luke's Cancer Network at St. Luke's Hospital

Related
1 trials

Shared therapeutic areas:

Melanoma (Skin)

Worked with same sponsors:

Cancer and Leukemia Group BChildren's Oncology Group+4 more
Collaborated on 1 trial
Similarity Score14%

Michael Smylie, MD, MB, ChB

Cross Cancer Institute at University of Alberta

Related
2 trials

Shared therapeutic areas:

Melanoma (Skin)

Worked with same sponsors:

Cancer and Leukemia Group BChildren's Oncology Group+4 more
Collaborated on 1 trial
Similarity Score14%

Alberto S. Pappo, MD

Texas Children's Cancer Center

Related
3 trials

Shared therapeutic areas:

Melanoma (Skin)

Worked with same sponsors:

Cancer and Leukemia Group BChildren's Oncology Group+4 more
Collaborated on 1 trial
Similarity Score14%

John M. Kirkwood, MD

UPMC Cancer Center at UPMC Presbyterian

Related
1 trials

Shared therapeutic areas:

Melanoma (Skin)

Worked with same sponsors:

Cancer and Leukemia Group BChildren's Oncology Group+4 more
Collaborated on 1 trial
Similarity Score14%

Lawrence E. Flaherty, MD

Barbara Ann Karmanos Cancer Institute

Related
3 trials

Shared therapeutic areas:

Melanoma (Skin)

Worked with same sponsors:

Cancer and Leukemia Group BChildren's Oncology Group+4 more
Collaborated on 1 trial
Similarity Score14%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LeukemiaLymphomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Gary Schiller, MD

University of California, Los Angeles

Related
3 trials

Shared therapeutic areas:

LeukemiaLymphoma
Similarity Score8%

Corey J. Langer, MD

Fox Chase Cancer Center

Related
16 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)SWOG Cancer Research Network
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00003641Phase 3StudyChair

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

Melanoma (Skin)
Completed
NCT00003451Phase 1StudyChair

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Completed

All 2 trials loaded